What is the ROE (Return on Equity) of Mediwound this year?
The ROE of Mediwound this year is -0.21 undefined.
Mediwound ROE 2025
Mediwound ROE
-0.21
Ticker
MDWD
ISIN
IL0011316309
WKN
A110TG
In 2025, Mediwound's return on equity (ROE) was -0.21, a -88.17% increase from the -1.8 ROE in the previous year.
Mediwound Aktienanalyse
What does Mediwound do?
Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Mediwound's Return on Equity (ROE)
Mediwound's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Mediwound's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Mediwound's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Mediwound’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Mediwound stock
How has the Return on Equity (ROE) of Mediwound developed compared to the previous year?
The ROE of Mediwound has increased by -88.17% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Mediwound?
A high ROE indicates that Mediwound generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Mediwound?
A low ROE can indicate that Mediwound is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Mediwound affect the company?
A change in ROE (Return on Equity) of Mediwound can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Mediwound?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Mediwound?
Some factors that can influence Mediwound's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Mediwound pay?
Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.
What is the dividend yield of Mediwound?
The current dividend yield of Mediwound is .
When does Mediwound pay dividends?
Mediwound pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mediwound?
Mediwound paid dividends every year for the past 0 years.
What is the dividend of Mediwound?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mediwound located?
Mediwound is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mediwound from 1/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/6/2025.
When did Mediwound pay the last dividend?
The last dividend was paid out on 1/6/2025.
What was the dividend of Mediwound in the year 2024?
In the year 2024, Mediwound distributed 0 USD as dividends.
In which currency does Mediwound pay out the dividend?
The dividends of Mediwound are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Mediwound
Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
